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INTRODUCTION 
Bilateral reduction mammoplasty (BRM) has long been used 
for cosmetic reasons. In recent years, BRM has also been used 
for the treatment of breast cancer. When used with radiother-
aphy in breast cancer patients, local recurrence of this proce-
dure has not been higher than that of modified radical mas-
tectomy [1,2]. If there is discordance between tumor size and 
breast volume, the cosmetic results of traditional breast-con-
serving surgical techniques such as quadranectomy or lumpec-
tomy have not been encouraging. The location of the primary 
tumor affects the cosmetic results. The amount of breast tissue 
removed with these techniques is much less than that in breast 
reduction, and symetrisation with the contralateral breast is 
therefore not a point at issue. If the breast volume is not reduced 
sufficiently with surgery, radiotherapy planning is quite diffi-
cult in breast cancer patients with macromastia. Given the 
proven safety of the oncological results of this procedure, it 
has been used with increasing frequency, particularly for mac-
romastic women with breast cancer. Good cosmetic results 
have been obtained with symetrisation, as well as with macro-
masty-related symptoms like back, neck, shoulder and arm 
pain, which were also relieved, and the radiotherapy planning 
was also eased. Therefore, this procedure has been called 
“symetrisation mammoplasty” and using this procedure has 
created similar results as different oncoplastic techniques used 
in different tumor localisations. Consequently, the tumor lo-
calisation does not alter the amount of tissue removed or the 
cosmetic results. 
The contralateral breast of a woman with breast carcinoma 
is at high risk for a new tumor. An important part of the con-
tralateral breast can be removed with surgery, and quite a large 
specimen can be obtained for pathological examination. This 
study evaluated the importance of a routine pathological ex-
amination of contralateral breast specimens in breast cancer 
patients using reduction mammoplasty.
METHODS
Seventy-one patients operated on with BRM due to breast 
cancer between 2008 and 2010 were enrolled in the study. Upper 
or lower pediculated flap techniques were preferred according 
to the location of the primary tumor in the breast. The same 
technique has also been used for symetrisation and reduction 
purposes on the contralateral breast. The age, height, weight, 
and body mass index (BMI) of the patients, tumor features and 
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Purpose: This study evaluated the importance of routine path-
ological examination of contralateral breast specimens in breast 
cancer patients using reduction mammoplasty. Methods: The 
weight of breast tissue resected from the contralateral breast in 
71 patients and the number of slices used for pathological evalu-
ation were recorded. Breast lesions found in the contralateral 
breast and accompanying lesions with tumors were examined. 
Results: High risk proliferative lesions were reported in the con-
tralateral breast of eight (11.2%) patients, and low-risk lesions 
were detected in 18 (25%). While the mean age of the patients 
with high-risk lesions was 45.6, it was 52.8 for the other patients 
(p=0.036). Conclusion: Bilateral reduction mammoplasty may be 
beneficial to delineate some pathologies in contralateral breasts 
even in those patients with normal clinical and radiological find-
ings. The incidental discovery of these pathologies is much more 
likely in young breast cancer patients. 
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stages, family history of breast cancer, the weight of breast tissues 
resected from the contralateral breast, and the number of tissue 
blocks prepared for pathological evaluation were recorded. 
Breast lesions found in the contralateral breast and accompa-
nying lesions with tumors were also examined.
Breast reduction specimens were examined macroscopical-
ly and, if no lesion was identified, eight to nine random blocks 
of breast tissue were prepared from the contralateral breast. If 
a macroscopic lesion was present, sampling was concentrated 
on that area, with selection of an appropriate number of blocks 
as considered necessary by the pathologist. Biopsy samples were 
fixed in 10% formalin, processed routinely, and embedded in 
paraffin. Sections (5 µm thick) were taken from the paraffin 
blocks and stained with H&E.
Ductal and lobular in situ carcinomas, atypical epithelial, and 
ductal and lobular hyperplasias were evaluated in proliferative 
lesions from the high-risk group. Severe (florid) and moderate 
hyperplasias without atypia, sclerosing adenosis, and intraductal 
papillomas were evaluated in the low-risk lesions group. Fibro-
cystic changes, mild hyperplasias, and fibroadenomas were 
evaluated in lesions of patients not in any risk group. 
Mammography and breast ultrasonography were used for 
preoperative contralateral breast evaluation. Patients with either 
clinical or radiological suspicious lesions in the contralateral 
breast were excluded. Therefore, patients requring breast MRI 
were also excluded.
A Student’s t-test was used in the comparison of patients with 
high risk lesions and other patients using SPSS version 10.00 
for Windows (SPSS Inc., Chicago, USA). p-values less than 
0.05 were accepted as significant.
RESULTS
 The median age of the patients was 51 years (range, 27-62 
years), the mean BMI 29±4.8, and median weight of the tis-
sue removed from contralateral breast was 1,080 g (range, 680- 
2,800 g). The general characteristics of the patients have been 
outlined in Table 1. Lower pediculated flaps in 53 patients (75%) 
and upper pediculated flaps in 18 patients (25%) were used. 
All patients were in T1 and T2 stage and sentinel lymph node 
biopsy was applied for axillary evaluation of tumor containing 
breasts. Fourteen patients with positive sentinel lymph node 
biopsy (SLNB) were operated on using axillary dissection, and 
all these patients were in stage N1. Incidentally discovered   
occult invasive carcinoma was not detected in the contralateral 
breast. Proliferative lesions with a high risk for breast carcino-
ma were reported in eight (11.2%) patients, three of whom 
exhibited ductal carcinoma in situ (DCIS) and the others, atyp-
ical ductal hyperplasia. Low-risk lesions were detected in 18 
patients (25%) with the following distribution: severe epitheli-
al hyperplasia in 10 patients, moderate epithelial hyperplasia 
in five patients, and sclerosing adenozis in three patients. Six-
teen patients were reported to have lesions without any risk of 
malignancy, and their distribution was as follows: 11 fibrocys-
tic changes, one mild epithelial hyperplasis, and one fibroade-
noma. No lesions were reported in 29 patients (40.8%). 
All three patients with atypical ductal hyperplasia were 
demonstrated to have a family history of breast cancer in first 
degree relatives; however, there were no lesions in another three 
patients with family histories. There were no patients with a 
family history of bilateral breast cancer in the study population. 
The mean age of the patients with high-risk lesions was 45.6, 
while the mean age of the rest was 52.8 (p=0.036). The mean 
weight of the specimens of lower and upper pediculated flaps 
removed from contralateral breast were 1,086 g and 1,060 g, 
respectively.
The lower pediculated flap technique was used in seven pa-
tients with high-risk lesions. The mean number of tissue blocks 
prepared from the contralateral breast was 9.8±2.1. The mean 
tissue block number for patients with high-risk lesions was 
11.2±2.4 (p=0.091). There was no difference between the 
patients with high-risk lesions and the others with respect to 
Table 1. General characteristics of patients
Characteristic Value
Age (yr)* 51 (27-62)
Height (cm)
† 163±27 
Weight (kg)
†   64±18 
Body mass index
†    29±4.8
Weight of contralateral breast specimen (g)  1,080 (680-2,800)
No. of tissue slices
†   9.8±2.1
*Median (range); 
†Mean±SD.
Table 2. Contralateral breast lesions and related parameters 
    Age (yr) Tumor size (cm) Specimen weight (g)   Slice no.
High risk lesions (11.2%)      45.6* 2.51±0.40 1,120±114 11.2±2.2
Low risk lesions (25%) 53 2.87±0.34 1,077±123   9.3±1.6
Lesions with no risk (22.5%)     53.4 2.79±0.43 1,074±118    10±1.7
Normal breast tissue (40.8%)     52.2 2.64±0.42 1,071±127 9.63±1.9
*p=0.036.
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tumor size (p=0.076) and specimen size excised (p=0.082). 
The single parameter demonstrated to increase the incidence 
of high-risk lesions in contralateral breast was young age (Table 
2). As the SLNB was negative at the site of the tumor-contain-
ing breast in eight patients with high-risk lesions in the contra-
lateral breast, axillary dissection was not applied. Three DCIS 
cases showed low grade lesions, one of whom had simple mas-
tectomy applied due to resection margin positivity. Adjuvant 
radiotheraphy and hormonotheraphy was added to the treat-
ment of the other two patients with negative resection margins. 
Patients with atypical epithelial hyperplasia were followed-up.
Accompanying lesions in the tumor-containing breast of the 
patients included three ductal in situ carcinomas, two atypical 
ductal hyperplasias, one lobular carcinoma in situ (LCIS), and 
one invasive carcinoma. There were no high-risk lesions in the 
contralateral breast of these patients. 
DISCUSSION
There have been no well-defined guidelines for the path- 
ological examination of specimens retrieved from contralater-
al breast specimens produced by reduction mammoplasty. In 
this study, although there were no suspicious lesions in a mac-
roscopic evaluation of the specimen, a microscopic evaluation 
was carried out with randomised 8-9 tissue blocks. When sus-
picious areas were defined, the specimens were evaluated in 
3-mm-thick slices. The number of tissue blocks taken was not 
determined according to the size of the specimen because a 
huge specimen made up of mostly fatty tissues was not sam-
pled like the fibrous rich ones. The series examining the lesions 
found after these surgeries have been mainly based on the series 
performed for benign reasons. The incidence of the occult in-
vasive breast carcinoma detection rate after BRM surgeries for 
benign reasons has ranged between 0.06% to 0.4% [3,4]. These 
low rates may be explained by the use of these surgeries in 
younger patients and radiological surveillance used before sur-
gery. Bondeson et al. [5] examined the lesions of 200 patients 
operated on with BRM for benign reasons and reported that 
while there was no pathological change in patients under the 
age of 30, LCIS was reported in 8% of the cases of patients over 
40 years of age. Ambaye et al. [6] reported high-risk lesions (in 
situ carcinoma and atypical hyperplasias) in 6.2% of patients 
over 40 years of age and 7.9% of patients over 50 years of age. 
In another study, high-risk lesions were reported to be 6.4% in 
patients over 40 years of age [3]. In these studies, the authors 
suggested a more careful examination of benign BRM speci-
mens in patients over 40 years of age. As the incidence of breast 
carcinoma increases with age, the increased frequency of high-
risk lesions with increasing age is not surprising in patients 
with no diagnosis of breast cancer. The incidence of contralat-
eral occult carcinoma in breast carcinoma patients operated on 
with BRM has increased up to 4% [6,7]. In a study comparing 
contralateral breast lesions in patients operated on for benign 
and malignant tumors, occult cancer and atypical proliferative 
lesion incidence in malignant cases were 2% and 7%, respec-
tively. These rates for benign cases were 0.6% and 1%, respec-
tively [8]. 
The annual absolute contralateral cancer risk for a patient 
with breast carcinoma is 0.7% [9]. The risk factors for bilateral 
breast cancer have been investigated extensively. Bilateral breast 
carcinoma risk has been demonstrated to be higher in patients 
with a diagnosis of breast carcinoma at an early age [10] of 
whom those with tumors greater than 2 cm are at higher risk 
[11] as those with familial bilateral breast cancer history, BRCA1 
and BRCA2 gene mutations, and LCIS [12,13]. 
In the past, blind biopsies in the upper outer quadrant or in 
areas mirror imaging sites of primary tumors have been used 
for early diagnosis of contralateral breast lesions [14]. 
It can be said that upper outer quadrant lesions can be de-
termined with the lower pediculated flap technique, while 
lower quadrant lesions can be determined with the upper pe-
diculated flap technique. In a series by Petit et al. [7] the upper 
pediculated flap technique was used in 80% of the cases and 
most of the occult lesions were detected in the lower quadrants 
and central areas. In our series, there was no difference in the 
amount of tissues resected using the two techniques. We have 
observed that the lower pediculated flap technique was used 
for seven of eight high-risk lesions which can be explained by 
the increased frequency of breast carcinomas in the upper outer 
quadrant and our low rate of upper pediculated flaps.
Can BRM decrease metachronous tumor incidence? Ricci 
et al. [15] followed 114 breast cancer patients treated with BRM 
and 134 not treated with BRM of similar age and stages for 51 
months. In the end, contralateral metachronous breast cancer 
incidence was 1.8% in the BRM group and 6.4% in the other 
group. Other studies have confirmed that this procedure de-
creases the risk of metachronous breast cancer [16]. In our series, 
there was no metachronous contralateral invasive and/or in 
situ carcinoma in our relatively short follow-up of 14 months. 
The vast majority of cases of high-grade DCIS with come-
donecrosis are recognised as microcalcifications in mammo-
graphic examinations. Nevertheless, low-grade DCIS cases are 
not detected in mammographies in 50-70% of cases [17]. We 
found that three DCIS cases detected were low-grade lesions. 
Further, in situ carcinomas that could not be recognised radio-
logically but were diagnosed within reduction specimens are 
expected to be low-grade lesions. 
We did not encounter any contralateral occult carcinomas 222  LutfiDogan,etal.
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in our series however, the incidence of high-risk proliferative 
lesions was 11.2% even in patients without any radiological 
abnormalities, and these patients were considerably younger. 
It has been found that the coincidence of high risk lesions in 
breast specimens of patients who underwent reduction mam-
moplasty for benign reasons such as macromastia increases 
with age [3,4]. However, the young age of the patients with 
breast cancer has been identified as a risk factor for high risk 
lesions in the contralateral breast [5]. It is well-known that     
genetic factors rather than enviromental factors are important 
in the etiology of breast cancer in young patients [12]. The 
tendency of these tumors for bilaterality and multicentricity 
might explain this occurence. Bilateral reduction mammo-
plasty is an effective measure to delineate the lesions in the 
contralateral breast. At least 8-9 tissue blocks should be taken 
to examine specimens that do not contain any macroscopic 
lesions. Further, young patients with a diagnosis of breast can-
cer and those with family histories of breast cancer are espe-
cially prone to high risk lesions in the contralateral breast. 
Therefore, contralateral specimens from these patients should 
be examined more carefully with a sufficient number of tissue 
blocks.
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